During TIDES: Europe 2018 (Euro TIDES), meet our experts to learn more about our oligonucleotide analytical development services. Booth 37 - 6-9 November 2018, Amsterdam, Netherlands
Intertek will present at TIDES: Europe 2018 on analytical development strategies which help to accelerate oligonucleotide product development from early characterisation to late-stage development & commercialization. meet our team at Booth 37.
Oligonucleotide Characterisation by NMR and Consideration of Orthogonal Techniques
An overview of NMR techniques for Oligonucleotide analysis, including a discussion on how NMR can be used in place of more conventional techniques for melting temperature calculation, the challenges presented by NMR and a reflection on regulatory aspects.
TRACK 2: CMC and Analytical Method Development Strategies
Thursday, 8 November 2018 15:15 - 15:45
Expert: Thomas Brown, Senior Analyst (Oligonucleotide Services), Intertek Pharmaceutical Services
Email firstname.lastname@example.org to request a copy of the presentation.
Case Study: Identification Testing by Accurate Mass and MS/MS Sequencing
White Paper: Analytical Strategies for Quality Control of Oligonucleotide Therapeutics
With a growing global development pipeline of oligonucleotide therapeutics to treat a variety of disease targets, overcoming the challenges of innovation, regulatory authorization, production and the inherent complexity of oligos is critical to success. Contact our experts in oligonucleotide analysis and bioanalysis, to discuss our regulatory-driven, phase-appropriate characterization and biophysical analysis in support of CMC programs which GMP and CMC laboratory services, pharmaceutical analysis, quality control analysis, elemental impurities, extractables and leachables, stability programs, inhalation drug development, method development and method validation will be available to review your challenges and discuss and how our unrivalled expertise can help you to accelerate the development timelines.
Need help or have a question?